Xunfei Healthcare Technology Co (HKSE:02506) Research & Development: HK$270 Mil (TTM As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:02506 Xunfei Healthcare Technology Co Ltd HKSE:02506
6 GF Score
Price HK$64.80
! 3 Warning Signs
View Full Analysis

What is Xunfei Healthcare Technology Co Research & Development?

Xunfei Healthcare Technology Co HKSE:02506 -0.61% 6 Research & Development is HK$270 Mil as of Dec. 2025. GuruFocus rates HKSE:02506 with a GF Score™ of 6/100. The stock has 3 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Xunfei Healthcare Technology Co's Research & Development for the six months ended in Dec. 2025 was HK$144 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 was HK$270 Mil.

Xunfei Healthcare Technology Co  (HKSE:02506) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Xunfei Healthcare Technology Co Research & Development Related Terms

Xunfei Healthcare Technology Co Research & Development Historical Data

* Premium members only.

The historical data trend for Xunfei Healthcare Technology Co's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Xunfei Healthcare Technology Co Research & Development Chart

Xunfei Healthcare Technology Co Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
195.65 269.77 288.72 290.29 270.94

Xunfei Healthcare Technology Co Semi-Annual Data
Dec21 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Research & Development Get a 7-Day Free Trial 149.77 145.64 145.84 125.16 144.44
HKSE:02506
6GF Score
Xunfei Healthcare Technology Co Ltd HKSE:02506
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Xunfei Healthcare Technology Co Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$270 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of HK$270 Mil mean?
Xunfei Healthcare Technology Co (HKSE:02506) has a Research & Development of HK$270 Mil as of Dec. 2025. Research and development expense is the total cost for research and development activities. View historical data on Xunfei Healthcare Technology Co and its competitors.
Is Xunfei Healthcare Technology Co's Research & Development too high?
Xunfei Healthcare Technology Co's current Research & Development is HK$270 Mil. Overall, Xunfei Healthcare Technology Co has a GF Score™ of 6/100, reflecting its overall financial health beyond just this single metric.
How does Xunfei Healthcare Technology Co's Research & Development compare to VEEV and BTSG?
Xunfei Healthcare Technology Co's Research & Development of HK$270 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Healthcare Providers & Services company?
A good Research & Development depends on the Healthcare Providers & Services industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Xunfei Healthcare Technology Co and its competitors. Xunfei Healthcare Technology Co's current Research & Development is HK$270 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Xunfei Healthcare Technology Co stock overvalued right now?
Xunfei Healthcare Technology Co (HKSE:02506) has a current Research & Development of HK$270 Mil. The current Research & Development is HK$270 Mil. Xunfei Healthcare Technology Co's overall GF Score™ is 6/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Xunfei Healthcare Technology Co (HKSE:02506), the current Research & Development is HK$270 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Xunfei Healthcare Technology Co Business Description

Address No. 666 Science and Innovation Road, High-tech Zone, 4 to 5/F (North Area), No.1 Building, Anhui Province, iFLYTEK AI Research and Development Production Bas, Chengxiqiao Community Services Center, Hefei, CHN
Xunfei Healthcare Technology Co Ltd is an AI-empowered healthcare solution provider, offering products and solutions that support a range of healthcare services, ranging from health risk warnings, early screening, auxiliary diagnosis and treatment, and treatment effect evaluation, to post-discharge management and chronic disease management. The company has independently developed AI technologies that underpin its products and solutions including Smart Healthcare, Smart Hospital, Smart Hardware, Smart Medical Insurance, and Smart Film Union.
6GF Score

Get the complete analysis for HKSE:02506

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$64.80
Price